[1] |
Du FZ, Zhang X, Zhang RL, et al. CARE⁃NS, a research strategy for neurosyphilis[J]. Front Med (Lausanne), 2022,9:1040133. doi: 10.3389/fmed.2022.1040133.
|
[2] |
Zhang HL, Lin LR, Liu GL, et al. Clinical spectrum of neurosyphilis among HIV⁃negative patients in the modern era[J]. Dermatology, 2013,226(2):148⁃156. doi: 10.1159/000347109.
|
[3] |
Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021[J]. MMWR Recomm Rep, 2021,70(4):1⁃187. doi: 10.15585/mmwr.rr7004a1.
|
[4] |
Janier M, Unemo M, Dupin N, et al. 2020 European guideline on the management of syphilis[J]. J Eur Acad Dermatol Venereol, 2021,35(3):574⁃588. doi: 10.1111/jdv.16946.
|
[5] |
Marra CM. Neurosyphilis[EB/OL]. UpToDate. (2020⁃08⁃12)[2023⁃05⁃12]. https://www.uptodate.com/contents/neurosyphilis.
|
[6] |
Tuddenham S, Katz SS, Ghanem KG. Syphilis laboratory guidelines: performance characteristics of nontreponemal antibody tests[J]. Clin Infect Dis, 2020,71(Suppl 1):S21⁃S42. doi: 10.1093/cid/ciaa306.
|
[7] |
Xiao Y, Li W, Li QL, et al. Which is the optimum antigen concentration for the venereal disease research laboratory test of cerebrospinal fluid for neurosyphilis diagnosis: 10 or 17 μl?[J]. Front Med (Lausanne), 2022,9:877186. doi: 10.3389/fmed.2022.877186.
|
[8] |
Birrell JM, Lowe M, Gunathilake M, et al. Neurosyphilis in the Northern Territory of Australia: a clinical guideline[J]. Intern Med J, 2023,53(5):738⁃744. doi: 10.1111/imj.15691.
|
[9] |
中国疾病预防控制中心性病控制中心, 中华医学会皮肤性病学分会性病学组, 中国医师协会皮肤科医师分会性病亚专业委员会. 梅毒、淋病和生殖道沙眼衣原体感染诊疗指南(2020年)[J]. 中华皮肤科杂志, 2020,53(3):168⁃179. doi: 10.35541/cjd.20190808.
|
[10] |
林路洋, 杨日东, 张锡宝, 等. 几种实验室检测方法在神经梅毒诊断中的比较[J]. 中华皮肤科杂志, 2011,44(2):127⁃129. doi: 10.3760/cma.j.issn.0412⁃4030.2011.02.019.
|
[11] |
Graham SH, Liu H. Life and death in the trash heap: The ubiquitin proteasome pathway and UCHL1 in brain aging, neurodegenerative disease and cerebral Ischemia[J]. Ageing Res Rev, 2017,34:30⁃38. doi: 10.1016/j.arr.2016.09.011.
|
[12] |
Oeckl P, Weydt P, Steinacker P, et al. Different neuroinflammatory profile in amyotrophic lateral sclerosis and frontotemporal dementia is linked to the clinical phase[J]. J Neurol Neurosurg Psychiatry, 2019,90(1):4⁃10. doi: 10.1136/jnnp⁃2018⁃318868.
|
[13] |
Heller C, Foiani MS, Moore K, et al. Plasma glial fibrillary acidic protein is raised in progranulin⁃associated frontotemporal dementia[J]. J Neurol Neurosurg Psychiatry, 2020,91(3):263⁃270. doi: 10.1136/jnnp⁃2019⁃321954.
|
[14] |
Khalil M, Teunissen CE, Otto M, et al. Neurofilaments as biomarkers in neurological disorders[J]. Nat Rev Neurol, 2018,14(10):577⁃589. doi: 10.1038/s41582⁃018⁃0058⁃z.
|
[15] |
Xie L, Li W, Ye WM, et al. Serum ubiquitin C⁃terminal hydrolase⁃L1, glial fibrillary acidic protein, and neurofilament light chain are good entry points and biomarker candidates for neurosyphilis diagnosis among patients without HIV to avoid lumbar puncture[J]. Clin Infect Dis, 2023,77(3):472⁃479. doi: 10.1093/cid/ciad158.
|
[16] |
Chen R, Lin LR, Xiao Y, et al. Evaluation of cerebrospinal fluid ubiquitin C⁃terminal hydrolase⁃L1, glial fibrillary acidic protein, and neurofilament light protein as novel markers for the diagnosis of neurosyphilis among HIV⁃negative patients[J]. Int J Infect Dis, 2023,127:36⁃44. doi: 10.1016/j.ijid.2022.11.013.
|
[17] |
Marra CM, Sahi SK, Tantalo LC, et al. Serum neurofilament light in neurosyphilis: a pilot study[J]. Sex Transm Dis, 2023,50(1):42⁃44. doi: 10.1097/OLQ.0000000000001717.
|
[18] |
Ghanem KG. REVIEW: Neurosyphilis: a historical perspective and review[J]. CNS Neurosci Ther, 2010,16(5):e157⁃e168. doi: 10.1111/j.1755⁃5949.2010.00183.x.
|
[19] |
Du FZ, Zhang HN, Li JJ, et al. Neurosyphilis in China: a systematic review of cases from 2009⁃2021[J]. Front Med (Lausanne), 2022,9:894841. doi: 10.3389/fmed.2022.894841.
|
[20] |
汤华阳, 高金平, 郭泽, 等. 131例神经梅毒患者临床特征及实验室检查结果分析[J]. 中华皮肤科杂志, 2020,53(10):774⁃780. doi: 10.35541/cjd.20200269.
|
[21] |
Marra CM, Maxwell CL, Smith SL, et al. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features[J]. J Infect Dis, 2004,189(3):369⁃376. doi: 10.1086/381227.
|
[22] |
Shen Y, Dong X, Liu J, et al. Serum interleukin⁃26 is a potential biomarker for the differential diagnosis of neurosyphilis and syphilis at other stages[J]. Infect Drug Resist, 2022,15:3693⁃3702. doi: 10.2147/IDR.S366308.
|
[23] |
Chen H, Zhou Y, Wang ZY, et al. Exosomal microRNA profiles from serum and cerebrospinal fluid in neurosyphilis[J]. Sex Transm Infect, 2019,95(4):246⁃250. doi: 10.1136/sextrans⁃2018⁃053813.
|
[24] |
王娜, 蒋法兴, 朱文, 等. 非梅毒螺旋体血清学试验持续阳性梅毒患者神经梅毒发生情况及影响因素分析[J]. 中华皮肤科杂志, 2016,49(5):314⁃317. doi: 10.3760/cma.j.issn.0412⁃4030.2016.05.004.
|